MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 297 filers reported holding MEDIVATION INC in Q3 2014. The put-call ratio across all filers is 1.15 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $302,000 | -17.9% | 5,000 | -37.5% | 0.02% | -14.3% |
| Q1 2016 | $368,000 | -4.9% | 8,000 | 0.0% | 0.02% | 0.0% |
| Q4 2015 | $387,000 | +13.8% | 8,000 | 0.0% | 0.02% | +10.5% |
| Q3 2015 | $340,000 | -25.6% | 8,000 | +100.0% | 0.02% | -17.4% |
| Q2 2015 | $457,000 | -11.4% | 4,000 | 0.0% | 0.02% | -11.5% |
| Q1 2015 | $516,000 | +29.6% | 4,000 | 0.0% | 0.03% | +30.0% |
| Q4 2014 | $398,000 | +0.3% | 4,000 | -0.2% | 0.02% | -4.8% |
| Q3 2014 | $397,000 | +28.5% | 4,010 | 0.0% | 0.02% | +162.5% |
| Q2 2014 | $309,000 | +19.8% | 4,010 | 0.0% | 0.01% | -42.9% |
| Q1 2014 | $258,000 | – | 4,010 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,484,101 | $148,897,000 | 79.45% |
| BB BIOTECH AG | 1,449,706 | $86,895,000 | 4.73% |
| SECTORAL ASSET MANAGEMENT INC | 1,013,529 | $60,751,000 | 2.92% |
| Orbimed Advisors | 2,284,500 | $136,933,000 | 2.44% |
| Archipel Asset Management AB | 191,016 | $11,449,000 | 2.35% |
| BENNETT LAWRENCE MANAGEMENT L L C/NY | 147,060 | $8,815,000 | 1.43% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 450,000 | $26,973,000 | 1.32% |
| QVT Financial LP | 305,128 | $18,289,000 | 1.24% |
| Bain Capital Public Equity Management, LLC | 825,687 | $49,492,000 | 1.24% |
| Tradeworx Inc. | 44,484 | $2,666,000 | 1.22% |